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Bacteria in the genus Vibrio produce extracellular proteolytic enzymes to obtain nutrients
via digestion of various protein substrates. However, the enzymes secreted by human
pathogenic species have been documented to modulate the bacterial virulence. Several
species including Vibrio cholerae and V. vulniﬁcus are known to produce thermolysin-
like metalloproteases termed vibriolysin. The vibriolysin from V. vulniﬁcus, a causative
agent of serious systemic infection, is a major toxic factor eliciting the secondary skin
damage characterized by formation of the hemorrhagic brae.The vibriolysin from intestinal
pathogens may play indirect roles in pathogenicity because it can activate protein toxins
and hemagglutinin by the limited proteolysis and can affect the bacterial attachment to or
detachment from the intestinal surface by degradation of the mucus layer. Two species
causing wound infections, V. alginolyticus and V. parahaemolyticus, produce another
metalloproteases so-called collagenases. Although the detailed pathological roles have
not been studied, the collagenase is potent to accelerate the bacterial dissemination
through digestion of the protein components of the extracellular matrix. Some species
produce cymotrypsin-like serine proteases, which may also affect the bacterial virulence
potential. The intestinal pathogens produce sufﬁcient amounts of the metalloprotease
at the small intestinal temperature; however, the metalloprotease production by extra-
intestinal pathogens is much higher around the body surface temperature. On the other
hand, the serine protease is expressed only in the absence of the metalloprotease.
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HUMAN PATHOGENIC VIBRIO SPECIES
Bacteria in the genus Vibrio are normal habitants of aquatic envi-
ronments and play important roles in maintaining the aquatic
ecosystem. Although more than 100 species are currently in this
genus, at least, 11 species listed in Table 1 are human pathogens
(Janda et al., 1988; Chakraborty et al., 1997). Amongst, Vibrio
hollisae is recommended to place into a novel genus Grimontia
(Thompson et al., 2003). Human pathogenic species can be clas-
siﬁed into two groups according to types of infectious diseases:
the group causing gastrointestinal diseases and that causing extra-
intestinal diseases. Representative species in the former group are
V. cholerae and V. parahaemolyticus, whereas V. vulniﬁcus is the
most important species in the latter group. Two species,V. damsela
and V. vulniﬁcus, are also ﬁsh pathogens.
Of humanpathogenic vibrios,V. cholerae is themost extensively
studied species because it is a causative agent of severe watery diar-
rheal disease, cholera. Cholera is characterized by uncontrolled
purging of copious rice water stools leading to serious electrolyte
depletion, dehydration, acidosis, shock, and, if left untreated, to
death. AlthoughV. cholerae is divided serologically into more than
200 groups, only two serogroups, O1 and O139, are etiologic
agents of epidemic cholera. The non-O1/non-O139 serogroups
are etiologic agents causing sporadic diarrheal cases and occa-
sionally extra-intestinal infections, including skin, ear, sputum,
urine, and cerebrospinal ﬂuid infections. Cholera toxin (CT) pro-
duced by the O1 and O139 serogroups is a major toxic factor
evoking severe watery diarrhea, whereas, hemolysin (Shinoda and
Miyoshi, 2006), Zonula occludens toxin (Fasano et al., 1991), and
accessory CT (Trucksis et al., 1993) have also been demonstrated
to be additional enterotoxic factors.
Vibrio parahaemolyticus inhabits commonly coastal and estu-
ary areas in the tropical and temperate regions, but this species has
been recognized to cause gastroenteritis following consumption
of seafood. The outstanding features of gastroenteritis are severe
abdominal pain, diarrhea (frequently bloody stools), nausea, vom-
iting, mild fever, and headache. The mean incubation period is 6
to 12 h and diarrhea or soft stools persist for 4–7 days. Although
the food poisoning caused by V. parahaemolyticus had been fre-
quent in Japan, the number of outbreaks has been decreased
drastically in the last 10 years. Production of the hemolysin
designated as thermostable direct hemolysin is closely related
to the bacterial pathogenicity (Shinoda and Miyoshi, 2006). V.
parahaemolyticus also causes wound-infection through exposure
of a new wound to contaminated seawater or estuarine water,
whereas this type of diseases is independent of production of the
hemolysin.
The ﬁrst clinical isolation of V. vulniﬁcus was from a human
leg ulcer (Roland, 1970). However, because of similar bacteri-
ological characteristics of the bacterium isolated, this case was
reported as an extra-intestinal infectious disease by V. para-
haemolyticus (Hollis et al., 1976). V. vulniﬁcus causes two types
of infections, the primary septicemia and the wound-infection,
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Table 1 | Infectious diseases caused byVibrio species.
Species
Intestinal diseases Extra-intestinal diseases
Cholera Diarrhea Septicemia Wound-infection Others*
V. alginolyticus ± ++ ±
V. cholerae O1/O139 ++
V. cholerae non O1/ non O139 ++ + + ±
V. cincinnatiensis ±
V. damsela +
V. ﬂuvialis ++
V. furnissii ±
V. hollisae ±
V. metschnikovii ± ±
V. mimicus ++ ±
V. parahaemolyticus ++ + ++ ±
V. vulniﬁcus ± ++ ++ ±
++, Major disease; +, Minor disease; ±, Rare disease.
*Include otitis media, cholesystitis, meningitis
to human (Blake et al., 1980; Klontz et al., 1988). The primary
septicemia is associated with consumption of contaminated raw
seafood, especially shellﬁsh such as oysters. However, this type
is a typical opportunistic infection. Namely, most patients have
an underlying disease(s) of liver dysfunction, alcoholic cirrho-
sis or hemochromatosis, which leads to increase in the plasma
ferric ion level and to decrease in the activity of the innate
immunity (Strom and Paranjpye, 2000; Inoue et al., 2008). In
two-thirds of the patients, the edematous and/or hemorrhagic
secondary skin lesions appear on the extremities and the trunk
(Blake et al., 1980; Inoue et al., 2008). The wound-infection is
characterized by the development of edema, erythema or necro-
sis around a new wound exposed to seawater contaminated with
V. vulniﬁcus (Blake et al., 1980; Klontz et al., 1988). This type
of infection can occur in healthy persons, as well as in the
immuno-compromised hosts, and may occasionally progress to
septicemia.
BACTERIAL EXTRACELLULAR PROTEOLYTIC ENZYMES
Human pathogenic vibrios produce various extracellular factors
including enterotoxin, hemolysin, cytotoxin, protease, collage-
nase, phospholipase, siderophore, and hemagglutinin (Janda et al.,
1988). Of these factors, enterotoxin, hemolysin, and cytotoxin are
directly related to the clinical symptoms; however, siderophore
and hemagglutinin may play roles in the establishment of the
infection.
Proteolytic enzymes hydrolyzing a peptide bond inproteins and
peptides are essential for the homeostatic control in both eukary-
otes and prokaryotes, and thus, the bacterial enzymes also have
various physiological roles in the life cycle of the microorganisms.
However, the enzymes produced by pathogenic species occasion-
ally act as toxic factors to the infected host (Hase and Finkelstein,
1993; Harrington, 1996). Proteolytic enzymes are classiﬁed into
several groups, such as aspartic, cysteine, and serine protease, and
metalloprotease; however,many of the bacterial toxic proteases are
in the metalloprotease group, which often contains a zinc (II) ion
in the catalytic center (Hase and Finkelstein, 1993; Hooper, 1994).
As shown in Table 2, human pathogenic Vibrio species also pro-
duce and secrete proteolytic enzymes, and several enzymes have
been extensively characterized as direct toxic factors causing skin
damage or indirect virulence factors processing other protein tox-
ins. The enzymes produced by vibrios are in two metalloprotease
groups (vibriolysin and collagenases) or one serine protease group
(chymotrypsin-like proteases).
The progress in the molecular biology has provided much
information on the DNA-derived amino acid sequences of metal-
loproteases and has shown the presence of the consensus sequence
HEXXH as the zinc-binding motif. This motif was also found
in some bacterial protein toxins including clostridial neurotoxins,
Table 2 | Extracellular proteolytic enzymes produced by pathogenic
Vibrio species.
Species
Metalloprotease Serine protease
Vibriolysin Collagenase Chymotrypsin-like
protease
V. alginolyticus + +
V. cholerae +
V. ﬂuvialis +
V. metschnikovii +
V. mimicus +
V. parahaemolyticus + +
V. vulniﬁcus + +
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Bacteroides fragilis enterotoxin, and Bacillus anthracis lethal factor.
Indeed, these bacterial toxins were veriﬁed to show the remarkably
speciﬁc proteolytic action toward a target host protein (Miyoshi
and Shinoda, 2000). For instance, clostridial neurotoxins can
cleave the restricted protein components of the neuroexocyto-
sis machinery, which leads to the blockade of neurotransmitter
release and consequent muscle paralysis (Schiavo et al., 1993). In
addition, a novel cytotoxin that consists of one A subunit and ﬁve
B subunits was isolated from some enterohemorrhagic Escherichia
coli strains, and the A subunit was indicated to be a subtilase-like
serine protease (Paton and Paton, 2010). The RTX (repeated-in-
toxin) toxins are large multifunctional cytotoxins and are possible
to modulate the virulence of a number of gram-negative bacte-
rial pathogens including V. cholerae and V. vulniﬁcus (Satchell,
2007; Prochazkova et al., 2009; Roig et al., 2011). In V. cholerae
RTX toxin, the cysteine protease domain was reported to medi-
ate autoprocessing of the toxin (Sheahan et al., 2007; Shen et al.,
2009).
VIBRIOLYSIN
BIOCHEMICAL PROPERTIES
Zinc-containing metalloproteaes consist of four superfamilies
based on the amino acid residues in the zinc-binding site, and
the zincins superfamily is characterized by the possessing of
the HEXXH motif (Hooper, 1994). The thermolysin family, in
which prototype enzyme is thermolysin from Bacillus thermo-
proteolyticus, is a one of major members of this superfamily.
The enzymes in this family are commonly characterized by the
presence of Glu at the 25th position from the ﬁrst His of the
above motif. V. proteolyticus is a marine microorganism that was
ﬁrst isolated from the intestine of a small, wood-boring iso-
pod crustacean (Merkel et al., 1964). Grifﬁn and Prescott (1970)
puriﬁed a highly active metalloprotease from the bacterial cul-
ture supernatant. Durham (1989) ﬁrst disclosed the designation
of this enzyme as vibriolysin in the patent literature. There-
after, highly homologous metalloproteases have been isolated
from other Vibrio species including human pathogens V. cholerae,
V. ﬂuvialis, V. mimicus, and V. vulniﬁcus. Therefore, the name
of vibriolysin is currently applicable to all of these proteolytic
enzymes (Miyoshi et al., 2012a).
Vibriolysin hydrolyzes speciﬁcally the peptide bond at the
amino group side of the P1′ amino acid residue, which is usu-
ally a hydrophobic amino acid reside (e.g., Phe, Tyr, or Leu;
Narukawa et al., 1993). Synthetic oligopeptides, such as carboben-
zoxy (Z)-Gly-Phe-NH2 and Z-Gly-Leu-NH2, are thus commonly
used as the suitable substrate. On the other hand, phosphorami-
don [N-(α-rhamnopyranosyloxy-hydroxyphosphanyl)Leu-Trp]
and zincov [2-(N-hydroxycarboxamido)-4-methylpentanoyl-Ala-
Gly amide] are well-known competitive inhibitors. In addition,
phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-Arg, the substrate
developed for bacterial collagenases, is signiﬁcantly hydrolyzed
by the enzyme (Miyoshi et al., 1987b). Vibriolysin is also
highly active on a wide variety of protein substrates. Namely,
the enzyme exhibits signiﬁcant proteolysis of casein, albumin,
hemoglobin, type I and IV collagen, gelatin, elastin, ﬁb-
rin, and ﬁbrinogen (Miyoshi et al., 1995; Miyoshi and Shinoda,
2000).
FIGURE 1 | Domain structure of vibriolysin, and direct toxic roles of
vibriolysin in the formation of the hemorrhagic brae.
Like thermolysin, vibriolysin is synthesized as an inactive pre-
cursor, and maturation of the precursor is achieved by several
processing stages (Chang et al., 2007). In the case of the enzyme
from V. vulniﬁcus (Figure 1), it is initially synthesized as the
preproenzyme (609 aa, 65,964 Da) with a typical signal peptide
(Cheng et al., 1996). The signal peptide is cleavedduring its passage
through the inner membrane in the signal peptidase-dependent
manner. In the periplasm, the propeptide that may function as an
intramolecular chaperone mediating maturation of the enzyme
and/or a speciﬁc inhibitor to protect autodigestion of the enzyme
(Chang et al., 2007) is then cleaved by an autocatalyticmechanism,
and ﬁnally, themature vibriolysin (413 aa, 44,648Da) is generated.
The vibriolysin maturated consists of two functional domains: the
N-terminal domain (314 aa, 34,049 Da) mediating the catalytic
action, and the C-terminal domain (99 aa, 10,656 Da) essential for
efﬁcient attachment to protein substrates (Yun et al., 2012). The
N-terminal domain is easily obtained by autocatalytic limited-
digestion of the C-terminal domain (Miyoshi et al., 1997). The
N-terminal domain alone possesses sufﬁcient proteolytic activity
toward oligopeptides or soluble proteins, while it shows markedly
reduced activity toward insoluble proteins such as type I collagen
and elastin.
The N-terminal domain of vibriolysin is signiﬁcantly related to
other enzymes in the thermolysin family; however, its C-terminal
domain may be unique. The feature of the proteolytic action,
which is mediated by the N-terminal domain, is considerably
similar to other enzymes. However, neither suitable speciﬁc pep-
tide substrate nor competitive inhibitor for vibriolysin has been
developed. On the other hand, the hemagglutinating action on
rabbit erythrocytes, which is due to association of bothN-terminal
and C-terminal domains with the erythrocyte membrane, is a
distinctive feature of vibriolysin so far as reported (Alam et al.,
1995).
PATHOLOGICAL ROLES
As summarized in Figure 2, a variety of pathological roles of vib-
riolysin have been documented (Shinoda and Miyoshi, 2011). In
the local infections such as the wound-infection, vibriolysin is
thought to be a direct toxic factor that causes hemorrhagic tissue
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FIGURE 2 | Pathological roles of extracellular proteolytic enzymes in infectious diseases caused byVibrio species.
damage throughdigestion of the basementmembrane around vas-
cular endothelial cells, and that forms edematous lesions through
generation of inﬂammatory mediators (Figure 1). The enzyme
from V. vulniﬁcus can enhance the vascular permeability when
injected into the mammalian dorsal skin. In rat skin, this reac-
tion is due to the release of histamine from mast cells, because
the vascular enhancement was abolished by simultaneous injec-
tion of diphenhydramine, an anti-histaminic agent (Miyoshi et al.,
1987c). In guinea pig skin, however, the permeability enhance-
ment is most likely due to activation of the factor XII-plasma
kallikrein-kinin cascade (Miyoshi et al., 1987a). Namely, the skin
reaction was not blocked by diphenhydramine, but it was modu-
lated by in situ administration of the speciﬁc inhibitors affecting
the cascade activation. Bradykinin, a well-known in vivo medi-
ator of inﬂammation, is ﬁnally generated through activation of
the cascade. Further studies to clarify the activationmechanism of
the human cascade have been carried out, and the results demon-
strated that vibriolysin could generate the active forms via limited
proteolysis of the inactive zymogens (Miyoshi et al., 2004). Plasma
prekallikrein was converted to the active kallikrein, which can lib-
erate bradykinin from kininogen, by cleavage of the Arg371-Ile372
bond. On the other hand, factor XII was activated by hydrolysis
of the Arg353-Val354 or Gly357-Leu358 bond, and activated factor
XII could convert plasma prekallikrein to kallikrein. Vibriolysin
also induces the hemorrhagic reaction in the mammalian dorsal
skin. The enzyme from V. vulniﬁcus showed the greatest hem-
orrhagic activity compared with some bacterial metalloproteases,
thermolysin from B. thermoproteolyticus, serralysin from Serratia
species, and collagenase from Clostridium histolyticum (Miyoshi
et al., 1998). The levels of the in vivo hemorrhagic activities of
these proteases were correlated with those of the in vitro prote-
olytic activities toward the reconstituted basement membrane gel.
Of two major basement components, laminin and type IV colla-
gen, only the latter was easily digested by vibriolysin. This indicates
that type IV collagen forming the framework of the basement
membrane is the target protein. Therefore, speciﬁc degradation of
type IV collagen causes destruction of the basement membrane,
breakdown of capillary vessels, and ﬁnally the leakage of blood
components including erythrocytes.
In the systemic infections including septicemia, vibriolysin
may act as a synergistic pathogenic factor through disordered
proteolysis of various plasma proteins, which in turn disturbs
the physiological homeostasis, and eventually elicits an immuno-
compromised state in the infected host. For instances, vibriolysin
has been documented to facilitate the bacterial infection by
disturbance of the plasma protease-protease inhibitor systems
(Miyoshi et al., 1995), and to interfere with the blood home-
ostasis through prothrombin activation and ﬁbrinolysis (Chang
et al., 2005; Kwon et al., 2007). Acceleration of the heme uti-
lization was also reported as the pathogenic role of vibriolysin
(Nishina et al., 1992). Ferric/ferrous ion is essential for in vivo
growth of pathogenic microorganisms. However, the concentra-
tion of free ferric/ferrous ion in human body is very low (10−15
to 10−18 M) because of the presence of heme-proteins includ-
ing hemoglobin and iron-binding proteins. Therefore, pathogenic
microorganisms invaded into human body must operate the sys-
tems to acquire ferric/ferrous ion. Heme, a complex of porphyrin
with ferric/ferrous ion and a prosthetic group in hemoglobin or
other heme-proteins, is often used as an iron source by human
pathogenic bacterial species (Stojiljkovic and Perkins-Balding,
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2002; Tong and Guo, 2009). Nishina et al. (1992) documented
that the vibriolysin-deﬁcient mutants of V. vulniﬁcus could not
grow in the iron-restricted broth because of the inability to utilize
hemoglobin as an iron source, but the bacterial growth was appar-
ently restored by the addition of the puriﬁed vibriolysin. On the
other hand, hemoglobin or ferric ion is known to be required for
efﬁcient transcriptionof the gene encoding the vibriolysin (Kawase
et al., 2004; Sun et al., 2006). Incidentally, it should be noted
that human plasma contains a broad-range protease inhibitor
α2-macroglobulin (α2 M) as a primary inhibitor for exogenous
proteolytic enzymes including bacterial enzymes. Vibriolysin was
also inactivated with α2 M at a molar ratio of 1:1 by means of
physical entrapment (Miyoshi and Shinoda, 1989). Therefore, the
pathological actions of vibriolysin documented herein are possible
to support the systemic infection but may be highly restricted in
vivo.
Vibriolysin from enteric pathogens may increase the bacte-
rial attachment to the intestinal surface through digestion of the
mucosal substances or the bacterial outer membrane proteins
(Alam et al., 2006). However, the inverse effect of the enzyme was
also known. The vibriolysin from V. cholerae O1 was reported to
accelerate the bacterial detachment from cultured cells by diges-
tion of V. cholerae adhesins (Finkelstein et al., 1992). Vibriolysin
also modulate the enterotoxicity of the bacterial toxins by lim-
ited proteolysis. For instance, the enzyme from V. cholerae O1
can activate CT through nicking of the A subunit of CT (Booth
et al., 1984). Vibriolysin also converts the precursor of the entero-
toxic hemolysin produced by V. cholerae to the mature toxin
through removal of the 15 kDaN-terminal propeptide (Nagamune
et al., 1996). Although the results shown above suggest indirect
pathogenic roles of vibriolysin, the possibility of the direct roles
has also been reported. Ghosh et al. (2006) puriﬁed vibriolysin
from a CT gene-negative strain of V. cholerae non-O1/non-O139
andmeasured the enterotoxic activity. The puriﬁed enzyme caused
accumulation of the hemorrhagic ﬂuid in the rabbit ileal loop
assay and increase in the intestinal short-circuit current in the
Using chamber assay. Additionally, through the analysis with sev-
eral mutants genetically constructed, Silva et al. (2006) showed
that vibriolysin was necessary for full expression of enterotoxicity
of V. cholerae O1.
COLLAGENASES
Yu and Lee (1999) and Kim et al. (2002) carried out cloning of
the V. parahaemolyticus gene encoding a collagenase, which was
designated as PrtV/PrtVp (562 aa, 63,156 Da) and VppC (814
aa, 89,833 Da), respectively. These enzymes were revealed to be
metalloproteases in the zincins superfamily having the consensus
zinc-binding HEXXH motif, but neither of the collagenases was
in the thermolysin family. Miyoshi et al. (2008) showed that, only
when V. parahaemolyticus was cultivated at 26◦C, the vppC gene
was sufﬁciently expressed, and VppC was secreted from the bac-
terial cell after removal of the N-terminal 72 amino acid residues.
In contrast, expression of the prtV/prtVp gene was negligible in
the wild type strain. The gene was signiﬁcantly expressed by dis-
ruption of the vppC gene; however, the product PrtV/PrtVp was
not secreted into the cultivation broth (Miyoshi et al., 2008), sug-
gesting PrtV/PrtVp is a cell-associated enzyme. VppC puriﬁed
showed the steady activity to hydrolyze Z-Gly-Pro-Gly-Gly-Pro-
Ala, the speciﬁc substrate for bacterial collagenases, and to digest
gelatin. This indicates that VppC may contribute to the wound-
infection by V. parahaemolyticus because putative digestion of
the components of the extracellular matrix by VppC may accel-
erate the bacterial dissemination and may form cellulitic skin
damage. V. alginolyticus, another species causing the wound-
infection, is known to produce a VppC homolog (Takeuchi et al.,
1992).
CHYMOTRYPSIN-LIKE PROTEASES
In 2002, two research groups reported individually puriﬁcation
of a serine protease, which was termed protease A and VPP1
respectively, from the culture supernatant of V. parahaemolyti-
cus (Ishihara et al., 2002; Lee et al., 2002). These proteases were
identical and corresponded to the VPA0227 protein (677 aa,
71,038 Da) of strain RIMD 2210633 (GenBank accession number:
BA000032). However, the amino acid sequencing of the puriﬁed
enzyme indicated that the N-terminal 121 amino acid residues
were removed during the maturating process. This serine protease
designated herein as protease A/VPP1 showed the immunological
cross-reactivity with serine proteases from V. metschnikovii and
V. alginolyticus (Ishihara et al., 2002). Indeed, protease A/VPP1
revealed highly similarity of the amino acid sequence to the
enzyme from V. metschnikovii (Kwon et al., 1995). Production
of protease A/VPP1 was much higher at 25 than 37◦C and was
induced by the addition of gelatin to the cultivation broth.Miyoshi
et al. (2008) reported that production of this serine protease was
remarkably increased by disruption of the vppC gene, suggest-
ing that protease A/VPP1 is a substitutive enzyme of VppC.
The puriﬁed protease was found to be sensitive to chymostatin,
the well-known competitive inhibitor for chymotrypsin, and
to hydrolyze the speciﬁc peptidyl-4-methyl-coumaryl-7-amide
(MCA) substrates for chymotripsin, such as Glutaryl-Ala-Ala-
Phe-MCA and Succinyl-Ala-Ala-Pro-Phe-MCA. Therefore, it may
be concluded that protease A/VPP1 is a chymotrypsin-like ser-
ine protease. The cytotoxicity against CHO, HeLa, or Vero cells
and the mouse lethal toxicity of puriﬁed protease A/VPP1 was
demonstrated by Lee et al. (2002). Our preliminary study showed
the proteolytic activity of the puriﬁed enzyme toward extracel-
lular matrix components, laminin and type I collagen. These
results suggest that protease A/VPP1 also modulate the bacterial
pathogenicity.
Vibrio vulniﬁcus sometime causes severe hemorrhagic sep-
ticemia called vibriosis in eels of the culture farms (Tison et al.,
1982; Biosca et al., 1991). A few strains isolated from diseases eels
were recently found to have lost the 80 kb genomic region includ-
ing the gene encoding vibriolysin, but instead of vibriolysin, these
strains secrete a serine protease termedVvsA,which is an ortholog
of protease A/VPP1 from V. parahaemolyticus (Miyoshi et al.,
2012b). As protease A/VPP1, production of VvsA was extremely
increased in the absence of the functional gene encoding vibri-
olysin (Wang et al., 2008). The vvsA gene constitutes an operon
with a downstream gene vvsB, of which product VvsB may act
as the chaperon supporting the maturation process of VvsA. The
database analysis showed that several Vbrio species including V.
parahaemolyticus have the homologus genes to vvsAB, indicating
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widely distribution of the chymotrypsin-like serine protease in
Vibrio species.
REGULATION OF PRODUCTION OF PROTEOLYTIC ENZYMES
Vibrio species are ubiquitous microorganisms in aquatic environ-
ments, but 11 species cause intestinal or extra-intestinal infections
to humans. During the infection process, the bacterial cells must
sense the change of environmental factors, such as tempera-
ture, pH, salinity, and osmolarity, and then, the bacterium must
transmit the signals into the cells through the speciﬁc signal-
transduction systems, which result in the change of expression
of the genes. Especially, the genes encoding the toxic or viru-
lence factors, which may be required for in vivo survival and
growth, must be expressed at an appropriate place and time in
a tightly regulated fashion (Heithoff et al., 1997; Lee et al., 1999).
Amongst the environmental factors, temperature is thought to be
the most important. The vibriolysin genes of the bacterium caus-
ing intestinal infections are expressed sufﬁciently at 37◦C, while
the genes of the bacterium causing extra-intestinal infections are
expressed more effectively around the body surface temperature
(Watanabe et al., 2004; Miyoshi et al., 2006). The gene expression
is also often affected by the salinity. For instance, the expres-
sion level of the vppC gene in V. parahaemolyticus is higher at
3% NaCl than 0.9% NaCl (Miyoshi et al., 2008). Although the
intracellular second messengers, such as cyclic AMP and cyclic
di-GMP, and the global general regulators including RpoS and
histone-like nucleotide structuring protein are also involved in
the gene regulation (Benitez et al., 2001; Wang et al., 2011, 2012),
the molecular mechanisms how the bacterium senses the envi-
ronmental signals and transmits the signals into the cells are not
clariﬁed.
Production of proteolytic enzymes is tightly dependent on the
growth phase and reaches to the maximum level at the early sta-
tionary phase. Many pathogenic bacteria coordinate expression of
the virulence genes in response to the bacterial cell density. This
regulation system is termed the quorum sensing (QS) and is con-
trolled by the small diffusible signal molecule called autoinducer
(AI; Whitehead et al., 2001; Henke and Bassler, 2004). At the low
cell density, the QS system cannot modulate the gene expression
because the concentration of AI is too low. However, at the high
cell density, the AI concentration around the bacterial cell reaches
the threshold level, theAImolecule is sensed by the sensor protein,
the signals are transmitted into the cell, and ﬁnally, the expression
of a set of genes is started or stopped.
In Vibrio species including V. cholerae, V. mimicus, and V. vul-
niﬁcus (Miller et al., 2002; Milton, 2006; Sultan et al., 2006), the AI
molecule is detected by the speciﬁc membrane-bound sensor pro-
tein, which causes conversion of the sensor protein from kinase to
phosphatase. Subsequently, the sensor protein/phosphatase medi-
ates dephosphorylation of LuxU-LuxO, the response regulator
proteins. The dephosphorylated LuxO has no activity to inhibit
LuxR or its homolog, the master transcriptional regulator for
the genes under the control of the QS system. Therefore, at the
high cell density, the transcriptional status of the target genes is
changed by the function of LuxR or its homologue. Production
of the proteolytic enzymes by pathogenic vibrios is closely related
with the extracellular AI level (Kim et al., 2003; Kawase et al., 2004;
Raychaudhuri et al., 2006). For instance, the mutant of the AI
synthetase showed apparently reduced production of vibriolysin.
Therefore, the QS system markedly controls the expression of the
proteolytic genes in Vibrio species. However, it should be noted
that the QS system of V. cholerae or V. mimicus is operated suf-
ﬁciently at 37◦C (Sultan et al., 2006), whereas, the system of V.
vulniﬁcus is operated effectively at 26◦C but not at 37◦C (Miyoshi
et al., 2006).
CONCLUSION
The proteolytic enzymes produced by human pathogenic Vibrio
species may play a variety of pathological roles: direct roles by
digesting many kinds of host proteins or indirect roles by pro-
cessing other toxic protein factors. Especially, vibriolysin from
V. vulniﬁcus is thought to be a major virulence factor. However,
some contradictions of the pathogenic roles were also reported
(Shao and Hor, 2000; Sun et al., 2006). It must be mentioned
that the puriﬁed enzymes from V. vulniﬁcus and V. proteolyticus, a
non-pathogenic species, are difﬁcult to distinguish in the in vivo
actions, because both enzymes are members of vibriolysin and
have comparative biochemical and toxic activities. However, it has
been demonstrated that the high growing ability of V. vulniﬁcus in
the mammal host is important for the pathogenicity of the bac-
terium (Watanabe et al., 2004). In addition, production of the toxic
or virulence factors including proteolytic enzymes is tightly regu-
lated by environmental factors, the bacterial cell density and so on.
Therefore, the overall experiments from various approaches are
necessary for evaluation of the extracellular proteolytic enzymes
as the virulence factors.
REFERENCES
Alam, M., Miyoshi, S., Ahmed, K. U., Hasan, N. A., Tomochika, K., and Shin-
oda, S. (2006). Proteolytic activation of Vibrio mimicus (Vm) major outer
membrane protein haemagglutinin (HA) with Vm-HA/protease: implication for
understanding bacterial adherence. Microbiol. Immunol. 50, 845–850.
Alam, M., Miyoshi, S., and Shinoda, S. (1995). Production of antigenically
related exocellular elastolytic proteases mediating hemagglutination by vibrios.
Microbiol. Immunol. 39, 67–70.
Benitez, J. A., Silva, A. J., and Finkelstein, R. A. (2001). Environmental signals
controlling of hemagglutinin/protease inVibrio cholerae. Infect. Immun. 69, 6549–
6553. doi: 10.1128/IAI.69.10.6549-6553.2001
Biosca, E. G., Amaro, C., Esteve, C., Alcaide, E., and Garay, E. (1991). First record of
Vibrio vulniﬁcus biotype 2 from diseased European eel, Anguilla anguilla. J. Fish
Dis. 14, 103–109. doi: 10.1111/j.1365-2761.1991.tb00581.x
Blake, P. A., Weaver, R. E., and Hollis, D. G. (1980). Disease of humans other
than cholera) caused by vibrios. Annu. Rev. Microbiol. 34, 341–367. doi:
10.1146/annurev.mi.34.100180.002013
Booth, B. A., Boesman-Finkelstein,M., and Finkelstein, R. A. (1984).Vibrio cholerae
hemagglutinin/protease nicks cholera enterotoxin. Infect. Immun. 45, 558–560.
Chakraborty, S., Nair, G. B., and Shinoda, S. (1997). Pathogenic vibrios
in the natural aquatic environment. Rev. Environ. Health 12, 63–80. doi:
10.1515/REVEH.1997.12.2.63
Chang, A. K., Ki, H. Y., Park, J. E., Acharya, P., Park, I. S., Yoon, S. M., et al. (2005).
Vibrio vulniﬁcus secretes a broad-speciﬁcity metalloprotease capable of interfer-
ing with blood homeostasis through prothrombin activation and ﬁbrinolysis. J.
Bacteriol. 187, 6909–6916. doi: 10.1128/JB.187.20.6909-6916.2005
Chang,A. K., Park, J.W., Lee, E. H., and Lee, J. S. (2007). The N-terminal propeptide
of Vibrio vulniﬁcus extracellular metalloprotease is both an inhibitor of and a
substrate for the enzyme. J. Bacteriol. 189, 6832–6838. doi: 10.1128/JB.00396-07
Cheng, J. C., Shao, C. P., and Hor, L. I. (1996). Cloning and nucleotide sequencing
of the protease gene of Vibrio vulniﬁcus. Gene 183, 255–257. doi: 10.1016/S0378-
1119(96)00488-X
Frontiers in Microbiology | Aquatic Microbiology November 2013 | Volume 4 | Article 339 | 6
“fmicb-04-00339” — 2013/11/14 — 21:12 — page 7 — #7
Miyoshi Proteolytic enzymes of vibrios
Durham, D. R. (1989). Cleaning compositions containing protease produced by
Vibrio and method of use. US Patent 4,865,983.
Fasano, A., Baudry, B., Pumplin, D. W., Wasserman, S. S., Tall, B. D., Kelly, J.
M., et al. (1991). Vibrio cholerae produces a second enterotoxin which affects
intestinal tight junctions. Proc. Natl. Acad. Sci. U.S.A. 86, 5242–5246. doi:
10.1073/pnas.88.12.5242
Finkelstein,R.A., Boesman-Finkelstein,M.,Chang,Y., andHase,C.C. (1992).Vibrio
cholerae hemagglutinin/protease, colonial variation, virulence, and detachment.
Infect. Immun. 60, 472–478.
Ghosh, A., Saha, D. R., Hoque, K. M., Asakuna, M., Yamasaki, S., Koley, H., et al.
(2006). Enterotoxigenicity of mature 45-kilodalton and processed 35-kilodaton
forms hemagglutinin protease pruriﬁed from a cholera toxin gene-negative Vib-
rio cholerae non-O1, non-O139 strain. Infect. Immun. 74, 2937–2946. doi:
10.1128/IAI.74.5.2937-2946.2006
Grifﬁn, T. B., and Prescott, J. M. (1970). Some physical characteris-
tics of a proteinase from Aeromonas proteolytica. J. Biol. Chem. 245,
1348–1356.
Harrington, D. J. (1996). Bacterial collagenases and collagen-degrading enzymes
and their role in human disease. Infect. Immun. 64, 1885–1891.
Hase, C. C., and Finkelstein, R. A. (1993). Bacterial extracellular zinc-containing
metalloproteases. Microbiol. Rev. 57, 823–837.
Heithoff, D. M., Conner, C. P., and Mahan, M. J. (1997). Dissecting the biology of
a pathogen during infection. Trends Microbiol. 5, 509–513. doi: 10.1016/S0966-
842X(97)01153-0
Henke, J. M., and Bassler, B. L. (2004). Bacterial social engagements. Trends Cell
Biol. 14, 648–656. doi: 10.1016/j.tcb.2004.09.012
Hollis, D. G., Weaver, R. E., Baker, C. N., and Thronsberry, C. (1976).
Halophilic Vibrio species isolated from blood cultures. J. Clin. Microbiol. 3,
425–431.
Hooper, N. M. (1994). Families of zinc metalloproteases. FEBS Lett. 354, 1–6. doi:
10.1016/0014-5793(94)01079-X
Inoue, Y., Ono, T., Matsui, T., Miyasaka, J., Kinoshita, Y., and Ihn, H.
(2008). Epidemiological survey of Vibrio vulniﬁcus infection in Japan between
1999 and 2003. J. Dermatol. 35, 129–139. doi: 10.1111/j.1346-8138.2008.
00432.x
Ishihara,M., Kawanishi, A.,Watanabe, H., Tomochika, K.,Miyoshi, S., and Shinoda,
S. (2002). Puriﬁcation of a serine protease of Vibrio parahaemolyticus and its
characterization. Microbiol. Immunol. 46, 298–303.
Janda, J. M., Power, C., Bryant, R. G., and Abbott, S. L. (1988). Current perspectives
on the epidemiology and pathogenesis of clinically signiﬁcant Vibrio spp. Clin.
Microbiol. Rev. 1, 245–267.
Kawase, T., Miyoshi, S., Sultan, Z., and Shinoda, S. (2004). Regulation system for
protease production in Vibrio vulniﬁcus. FEMS Microbiol. Lett. 240, 55–59. doi:
10.1016/j.femsle.2004.09.023
Kim, S. Y., Lee, S. E., Kim, Y. R., Kim, C. M., Ryu, P. Y., Choy, H. E., et al. (2003).
Regulation of Vibrio vulniﬁcus virulence by the LuxS quorum-sensing system.
Mol. Microbiol. 8, 1647–1664. doi: 10.1046/j.1365-2958.2003.03536.x
Kim, S. K., Yang, J. Y., and Cha, J. (2002). Cloning and sequence analysis of a novel
metalloprotease gene from Vibrio parahaemolyticus 04. Gene 283, 277–286. doi:
10.1016/S0378-1119(01)00882-4
Klontz, K. C., Lieb, S., Schreiber, M., Janowski, H. T., Baldy, L., and Gunn, R.
A. (1988). Syndromes of Vibrio vulniﬁcus infections: clinical and epidemiolog-
ical features in Florida cases, 1981–1987. Ann. Intern. Med. 109, 318–323. doi:
10.7326/0003-4819-109-4-318
Kwon, J. Y., Chang, A. K., Park, J. E., Shing, S. Y., Yoon, S. M., and Lee, J. S.
(2007).Vibrio extracellular protease with prothrombin activation and ﬁbrinolytic
activities. Int. J. Mol. Med. 19, 157–163.
Kwon, Y. T., Kim, J. O., Moon, S. Y., Yoo, Y. D., and Rho, H. M. (1995). Cloning and
characterization of the gene encoding an extracellular alkaline serine protease
from Vibrio metschnikovii strain RH530. Gene 152, 59–63. doi: 10.1016/0378-
1119(94)00648-C
Lee, C. Y., Cheng, M. F., Yu, M. S., and Pan, M. J. (2002). Puriﬁcation and
characterization of a putative virulence factor, serine protease, from Vibrio
parahaemolyticus. FEMS Microbiol. Lett. 209, 31–37. doi: 10.1111/j.1574-
6968.2002.tb11105.x
Lee, S. H., Hava, D. L., Waldor, M. K., and Camilli, A. (1999). Regulation and
temporal expression patterns of Vibrio cholerae virulence genes during infection.
Cell 99, 625–634. doi: 10.1016/S0092-8674(00)81551-2
Merkel, J. R., Traganza, E. D., Mukherjee, B. B., Grifﬁn, T. B., and
Prescott, J. M. (1964). Proteolytic activity and general characteristics
of a marine bacterium, Aeromonas proteolytica sp. N. J. Bacteriol. 87,
1227–1233.
Miller, M. B., Skorupski, K., Lenz, D. H., Taylor, R. K., and Bassler, B. L. (2002).
Parallel quorum sensing systems converge to regulate virulence inVibrio cholerae.
Cell 110, 303–314. doi: 10.1016/S0092-8674(02)00829-2
Milton, D. L. (2006). Quorum sensing in vibrios: complexity for diversiﬁcation. Int.
J. Med. Microbiol. 296, 61–71. doi: 10.1016/j.ijmm.2006.01.044
Miyoshi, N., Miyoshi, S., Sugiyama, K., Suzuki, Y., Furuta, H., and Shinoda, S.
(1987a). Activation of the plasma kallikrein-kinin system by Vibrio vuniﬁcus
protease. Infect. Immun. 55, 1936–1939.
Miyoshi, N., Shimizu, C., Miyoshi, S., and Shinoda, S. (1987b). Puriﬁcation and
characterization of Vibrio vulniﬁcus protease. Microbiol. Immunol. 31, 13–25.
Miyoshi, S., Sugiyama, K., Suzuki, Y., Furuta, H., Miyoshi, N., and Shinoda, S.
(1987c). Enhancement of vascular permeability due to histamine-releasing effect
ofVibrio vulniﬁcus protease. FEMSMicrobiol. Lett. 40, 95–98. doi: 10.1111/j.1574-
6968.1987.tb01989.x
Miyoshi, S., Narukawa, H., Tomochika, K., and Shinoda, S. (1995). Actions of Vib-
rio vulniﬁcus metalloprotease on human plasma proteinase-proteinase inhibitor
systems: a comparative study of native protease with its derivative modiﬁed by
polyethylene glycol. Microbiol. Immunol. 39, 959–966.
Miyoshi, S., Nakazawa, H., Kawata, K., Tomochika, K., Tobe, K., and Shinoda, S.
(1998). Characterization of the hemorrhagic reaction caused by Vibrio vulniﬁcus
metalloprotease, a member of the thermolysin family. Infect. Immun. 66, 4851–
4855.
Miyoshi, S., Nitanda, Y., Fujii, K., Kawahara, K., Li, T., Maehara, Y., et al. (2008).
Differential expression and extracellular secretion of the collagenolytic enzymes
by the pathogen Vibrio parahaemolyticus. FEMS Microbiol. Lett. 283, 176–181.
doi: 10.1111/j.1574-6968.2008.01159.x
Miyoshi, S., Okamoto, K., and Takahashi, E. (2012a) “Vibriolysin,” in Handbook
of Proteolytic Enzymes, 3rd Ed, eds N. D. Rawlings and G. Salvesen (London:
Academic Press), 579–582.
Miyoshi, S., Wang, J., Katoh, K., Senoh, M., Mizuno, T., and Maehara,
Y. (2012b). An extracellular serine protease produced by Vibrio vulniﬁcus
NCIMB 2137, a metalloprotease-gene negative strain isolated from a diseased
eel. World J. Microbiol. Biotechnol. 28, 1633–1639. doi: 10.1007/s11274-011-
0969-y
Miyoshi, S., and Shinoda, S. (1989). Inhibitory effects of 2-macriglobulin on Vibrio
vulniﬁcus proteae. J. Biochem. 106, 299–303.
Miyoshi, S., and Shinoda, S. (2000). Microbial metalloproteases and pathogenesis.
Microbes Infect. 2, 91–98. doi: 10.1016/S1286-4579(00)00280-X
Miyoshi, S., Sultan, S. Z., Yasuno, Y., and Shinoda, S. (2006). Growth phase-
dependent production of a toxic mtalloprotease by Vibrio vulniﬁcus. Toxin Rev.
25, 19–30. doi: 10.1080/15569540500320862
Miyoshi, S.,Wakae, H., Tomochika, K., and Shinoda, S. (1997). Functional domains
of a zinc metalloprotease from Vibrio vulniﬁcus. J. Bacteriol. 179, 7606–7609.
Miyoshi, S., Watanabe, H., Kawase, T., Yamada, H., and Shinoda, S. (2004). Gen-
eration of active fragments from human zymogens in the bradykinin-generating
cascade by extracellular proteases fromVibrio vulniﬁcus andV. parahaemolyticus.
Toxicon 44, 887–893. doi: 10.1016/j.toxicon.2004.08.013
Nagamune, K., Yamamoto, K., Naka, A., Matsuyama, J., Miwatani, T., and Honda,
T. (1996). In vitro proteolytic processing and activation of the recombinant
precursor of El Tor cytolysin/hemolysin (pro-HlyA) of Vibrio cholerae by sol-
uble hemagglutinin/protease of V. cholerae, trypsin, and other proteases. Infect.
Immun. 64, 4655–4658.
Narukawa, H.,Miyoshi, S., and Shinoda, S. (1993). Chemical modiﬁcation of Vibrio
vulniﬁcus metalloprotease with activated polyethylene glycol. FEMS Microbiol.
Lett. 108, 43–46. doi: 10.1111/j.1574-6968.1993.tb06071.x
Nishina, Y., Miyoshi, S., Nagase, A., and Shinoda, S. (1992). Signiﬁcant role of an
exocellular protease in utilization of heme byVibrio vulniﬁcus. Infect. Immun. 60,
2128–2132.
Paton, A. W., and Paton, J. C. (2010). Escherichia coli subtilase cytotoxin. Toxins 2,
215–228. doi: 10.3390/toxins2020215
Prochazkova, K., Shuvalova, L. A., Minasov, G., Voburka, Z., Anderson, W. F., and
Satchell, K. J. F. (2009). Structural and molecular mechanism for autoprocessing
of MARTX toxin of Vibrio cholerae at multiple sites. J. Biol. Chem. 284, 26557–
26568. doi: 10.1074/jbc.M109.025510
www.frontiersin.org November 2013 | Volume 4 | Article 339 | 7
“fmicb-04-00339” — 2013/11/14 — 21:12 — page 8 — #8
Miyoshi Proteolytic enzymes of vibrios
Raychaudhuri, S., Jain, V., and Dongre, M. (2006). Identiﬁcation of a constitutively
active variant of LuxO that affects production of HA/protease and bioﬁlm devel-
opment in a non-O1, non-O139 Vibrio cholerae O110. Gene 369, 126–133. doi:
10.1016/j.gene.2005.10.031
Roig, F. J., Gonzalez-Candelas, F., and Amaro, C. (2011). Domain organization and
evolution of multifunctional autoprocessing repeats-in-toxin (MARTX) toxin
in Vibrio vulniﬁcus. Appl. Environ. Microbiol. 77, 657–668. doi: 10.1128/AEM.
01806-10
Roland, F. P. (1970). Leg gangrene and endotoxin shock due toVibrio parahaemolyti-
cus: an infection acquired in New England coastal water. New Engl. J. Med. 282,
1306. doi: 10.1056/NEJM197006042822306
Satchell, K. J. F. (2007). MARTX, multifunctional autoprocessing repeats-in-toxin
toxins. Infect. Immun. 75, 5079–5084. doi: 10.1128/IAI.00525-07
Schiavo, G., Poulain, B., Benfenati, F., DasGupta, B. R., and Montecucco, C. (1993).
Novel targets and catalytic activities of bacterial protein toxins. Trends Microbiol.
1, 170–174. doi: 10.1016/0966-842X(93)90086-7
Shao, C. P., and Hor, L. (2000). Metalloprotease is not essential for Vibrio vulniﬁcus
virulence in mice. Infect. Immun. 68, 3569–3573. doi: 10.1128/IAI.68.6.3569-
3573.2000
Sheahan, K. L., Cordero, C. L., and Satchell, K. J. F. (2007). Autoprocessing of
the Vibrio cholerae RTX toxin by the cysteine protease domain. EMBO J. 26,
2552–2561. doi: 10.1038/sj.emboj.7601700
Shen, A., Lupardus, P., Albrow, V. E., Guzetta, A., Powers, J. C., Garcia, K.
C., et al. (2009). Mechanistic and structural insights into the proteolytic acti-
vation of Vibrio cholerae MARTX toxin. Nat. Chem. Biol. 5, 469–478. doi:
10.1038/nchembio.178
Shinoda, S., andMiyoshi, S. (2006). “Hemolysins ofVibrio cholerae and otherVibrio
species,” in Comprehensive Sourcebook of Bacterial Protein Toxins, 3rd Ed, eds J. F.
Alouf and M. R. Popoff (London: Academic Press), 748–762.
Shinoda, S., and Miyoshi, S. (2011). Proteases produced by vibrios. Biocontrol Sci.
16, 1–11. doi: 10.4265/bio.16.1
Silva, A. J., Leitch, G. J., Camilli. A., and Beitez, J. A. (2006). Contribution
of hemagglutinin/protease and motility to the pathogenesis of el tor bio-
type cholera. Infect. Immun. 74, 2072–2079. doi: 10.1128/IAI.74.4.2072-2079.
2006
Stojiljkovic, I., and Perkins-Balding, D. (2002). Processing of heme and
heme-containing proteins by bacteria. DNA Cell Biol. 21, 281–295. doi:
10.1089/104454902753759708
Strom, M. S., and Paranjpye, R. N. (2000). Epidemiology and pathogenesis of
Vibrio vulniﬁcus. Microbes Infect. 2, 177–188. doi: 10.1016/S1286-4579(00)
00270-7
Sultan, Z., Miyoshi, S., and Shinoda, S. (2006). Presence of LuxS/AI-2 based
quorum-sensing system in Vibrio mimicus: LuxO controls pretease activity.
Microbiol. Immunol. 50, 407–417.
Sun, H. Y., Han, S. I., Choi, M. H., Kim, S. J., Kim, C. M., and Shin, S. H. (2006).
Vibrio vulniﬁcus metalloprotease VvpE has no direct effect on iron-uptake from
human hemoglobin. J. Microbiol. 44, 537–547.
Takeuchi, H., Shibano, Y., Morihara, K., Fukushima, J., Inami, S., Keil, B., et al.
(1992). Structural gene and complete amino acid sequence of Vibrio alginolyticus
collagenase. Biochem. J. 281, 703–708.
Thompson, F. L., Hoste, G., Vandemeulebroecke, K., and Swing, J. (2003).
Reclassiﬁcation of Vibrio hollisae as Grimontia hollisae gen. nov., comb.
nov. Int. J. Syst. Evol. Microbiol. 53, 1615–1617. doi: 10.1099/ijs.0.
02660-0
Tison, D. L., Nishibuchi, M., Greenwood, J. D., and Seidler, R. J. (1982). Vibrio
vulniﬁcus biotype 2: new biogroup pathogenic for eels. Appl. Environ. Microbiol.
44, 640–646.
Tong, Y., and Guo, M. (2009). Bacterial heme-transport proteins and
their heme-coordination modes. Arch. Biochem. Biophys. 481, 1–15. doi:
10.1016/j.abb.2008.10.013
Trucksis, M., Galen, J. E., Michalski, J., Fasano, A., and Kaper, J. B. (1993). Accessory
cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette.
Proc. Natl. Acad. Sci. U.S.A. 90, 5267–5271. doi: 10.1073/pnas.90.11.5267
Wang, H. X., Ayala, J. C., Benitez, J. A., and Silva, A. J. (2012). Interac-
tion of the histone-like nucleotide structuring protein and the general stress
response regulator RpoS at Vibrio cholerae promoters that regulate motil-
ity and hemagglutinin/protease expression. J. Bacteriol. 194, 1205–1215. doi:
10.1128/JB.05900-11
Wang, J., Sasaki, T., Maehara, Y., Nakao, H., Tsuchiya, T., and Miyoshi, S.
(2008). Variation of extracellular proteases produced by Vibrio vulniﬁcus clin-
ical isolates: genetic diversity of the metalloprotease gene (vvp), and serine
protease secretion by vvp-negative strains. Microbiol. Pathog. 44, 494–500. doi:
10.1016/j.micpath.2008.01.001
Wang, H. X., Wu, J. H., Ayala, J. C., Benitez, J. A., and Silva, A. J. (2011). Interplay
among cyclic diguanylate, HapR, and the general stress response regulator (RpoS)
in the regulation of Vibrio cholerae hemagglutinin/protease. J. Bacteriol. 193,
6529–6538. doi: 10.1128/JB.05166-11
Watanabe, H., Miyoshi, S., Kawase, T., Tomochika, K., and Shinoda, S. (2004).
High growing ability of Vibrio vulniﬁcus biotype 1 is essential for production of a
toxic metalloprotease causing systemic diseases in humans. Microbiol. Pathog. 36,
117–123. doi: 10.1016/j.micpath.2003.10.001
Whitehead, N. A., Barnard, A. M., Slater, H., Simpson, N. J., and Salmond, G. P.
(2001). Quorum-sensing in Gram-negative bacteria. FEMS Microbiol. Rev. 25,
365–404. doi: 10.1111/j.1574-6976.2001.tb00583.x
Yu, M. S., and Lee, C. Y. (1999). Expression and characterization of the prtV
gene encoding a collagenase from Vibrio parahaemolyticus in Escherichia coli.
Microbiology 145, 143–150. doi: 10.1099/13500872-145-1-143
Yun, J. H., Kim, H., Park, J. E., Lee, J. S., and Lee, W. (2012). Solution structure
and dynamics of C-terminal regulatory domain of Vibrio vulniﬁcus extracel-
lular metalloprotease. Biochem. Biophys. Res. Commun. 430, 541–546.doi:
10.1016/j.bbrc.2012.11.117
Conflict of Interest Statement:The author declares that the researchwas conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 28 August 2013; paper pending published: 03 October 2013; accepted: 26
October 2013; published online: 18 November 2013.
Citation: Miyoshi S (2013) Extracellular proteolytic enzymes produced by human
pathogenic Vibrio species. Front. Microbiol. 4:339. doi: 10.3389/fmicb.2013.00339
This article was submitted to Aquatic Microbiology, a section of the journal Frontiers
in Microbiology.
Copyright © 2013 Miyoshi. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or repro-
duction in other forums is permitted, provided the original author(s) or licensor are
credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Microbiology | Aquatic Microbiology November 2013 | Volume 4 | Article 339 | 8
